| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Chief Development Officer
1 company
Yea Christopher is a Chief Development Officer at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $6.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 914 | $17.00 | $15,539.28 | -1.1% | |
| Feb 5, 2020 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sell | 100 | $17.10 | $1,710.00 | -0.1% | |
| Dec 20, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 2,646 | $17.02 | $45,025.13 | -3.1% | |
| Dec 16, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 4,709 | $17.05 | $80,269.34 | -1.9% | |
| Jul 22, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,355 | $18.35 | $134,929.68 | -8.1% | |
| Apr 22, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 7,355 | $26.04 | $191,529.84 | -4.2% | |
| Jan 25, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 5,453 | $17.06 | $93,015.09 | -6.2% | |
| Jan 23, 2019 | KALV Kalvista Pharmaceuticals, Inc. | Chief Development Officer | Sale+OE | 1,902 | $17.01 | $32,343.93 | -1.1% |